Pregnancy and breastfeeding in women with multiple sclerosis

Nervenarzt. 2024 Feb 23. doi: 10.1007/s00115-024-01621-9. Online ahead of print.ABSTRACTThe diagnosis of multiple sclerosis (MS) in women of reproductive age is associated with many uncertainties regarding childbearing and lactation. Pregnancies of MS patients are not usually considered high-risk pregnancies per se. The likelihood of pregnancy complications or adverse pregnancy outcomes is not increased by the disease; however, a careful planning of pregnancy is important in order to choose the treatment option with the greatest benefit for the mother and the least possible risk for the baby. For highly active courses of the disease, anti-CD20 antibodies, cladribine, or continued administration of natalizumab show the best data. Patients with MS can be supported in their desire to breastfeed. If women have had a very active disease course, it is recommended that treatment should be started as soon as possible postpartum. Interferon-beta preparations, glatiramer acetate and ofatumumab are also approved for use during breastfeeding but off-label breastfeeding is also possible with other monoclonal antibodies.PMID:38393359 | DOI:10.1007/s00115-024-01621-9
Source: Der Nervenarzt - Category: Neurology Authors: Source Type: research